These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22824780)

  • 21. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Zhang B; Zhang Y; Yu D
    Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
    Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
    J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
    Guo W; Li A; Jia Z; Yuan Y; Dai H; Li H
    Eur J Pharmacol; 2013 Oct; 718(1-3):41-7. PubMed ID: 24070814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxystress inducing antitumor therapeutics via tumor-targeted delivery of PEG-conjugated D-amino acid oxidase.
    Fang J; Deng D; Nakamura H; Akuta T; Qin H; Iyer AK; Greish K; Maeda H
    Int J Cancer; 2008 Mar; 122(5):1135-44. PubMed ID: 17990314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.
    De Miguel D; Gallego-Lleyda A; Ayuso JM; Pejenaute-Ochoa D; Jarauta V; Marzo I; Fernández LJ; Ochoa I; Conde B; Anel A; Martinez-Lostao L
    Cancer Lett; 2016 Dec; 383(2):250-260. PubMed ID: 27725224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer.
    Kursa M; Walker GF; Roessler V; Ogris M; Roedl W; Kircheis R; Wagner E
    Bioconjug Chem; 2003; 14(1):222-31. PubMed ID: 12526712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
    Hong M; Zhu S; Jiang Y; Tang G; Pei Y
    J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transferrin conjugated PEG-liposomes as intracellular targeting carrier for tumor therapy].
    Ishida O; Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):657-62. PubMed ID: 9549352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
    Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GMP production and characterization of leucine zipper-tagged tumor necrosis factor-related apoptosis-inducing ligand (LZ-TRAIL) for phase I clinical trial.
    Jiang J; Liu X; Deng L; Zhang P; Wang G; Wang S; Liu H; Su Y
    Eur J Pharmacol; 2014 Oct; 740():722-32. PubMed ID: 24929054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
    Nag M; Gajbhiye V; Kesharwani P; Jain NK
    Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
    Vaidya B; Vyas SP
    J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxicity of novel pro-apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL.
    Skidan I; Miao B; Thekkedath RV; Dholakia P; Degterev A; Torchilin V
    Drug Deliv; 2009 Jan; 16(1):45-51. PubMed ID: 19555308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
    Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
    Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16.
    Upadhyay P; Sarker S; Ghosh A; Gupta P; Das S; Ahir M; Bhattacharya S; Chattopadhyay S; Ghosh S; Adhikary A
    Biomater Sci; 2019 Oct; 7(10):4325-4344. PubMed ID: 31411213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of Apo2L/TNF-related apoptosis-inducing ligand-loaded human serum albumin nanoparticles with improved stability and tumor distribution.
    Kim TH; Jiang HH; Youn YS; Park CW; Lim SM; Jin CH; Tak KK; Lee HS; Lee KC
    J Pharm Sci; 2011 Feb; 100(2):482-91. PubMed ID: 20669330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.